Artwork

Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Maya Zlatanova: Setting the clinical trial up for success by listening to the healthcare ecosystem

35:55
 
공유
 

Manage episode 382347604 series 3526489
Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Send us a text

We speak to Maya Zlatanova, the CEO and Founder of Trialhub and FindMeCure about trial strategy for clinical trials. We speak about the amount of information necessary to digest in order to answer the many complex questions during trial start-up, and how starting from the templates of previous trials can both be time-saving, but may also limit your perspective on what is possible with this specific trial.

By asking the question of “what can go wrong” can help open the innovative power of clinical trial design. This can also help the understanding of patients and sites in the real world, and lead to better decisions. This question can also lead to better empathy with the stakeholders, and help anticipate some of the issues that may arise in the trial based on the design.

Finding data that can reliably support the answer for this question is another challenge yet to be solved. This is complicated further by the collaboration between the CROs and sponsors, where the responsibility to collect the data necessary to support key decisions may fall between two chairs.

Aligning your clinical trial to the real world would ideally lead to adjustments of the clinical trial as it is ongoing - but that is prohibitively expensive and difficult. When you are having trouble recruiting patients for your trial though, it may be worth the cost to pivot your trial during conduct. Here patient listening may be a way to understand what else might be possible for your trial.

Patient recruitment slowing down may be a lagging indicator of trouble with your trial design. Having conversations with your investigators proactively can help you uncover potential issues with your trial before they manifest as recruitment problems. Understanding the entire ecosystem that the clinical trial takes place in can help you understand which alternatives to participating in a trial the patients may value more.

Guest:

Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/

Trialhub and FindMeCure: https://trialhub.findmecure.com/

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

  continue reading

67 에피소드

Artwork
icon공유
 
Manage episode 382347604 series 3526489
Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Send us a text

We speak to Maya Zlatanova, the CEO and Founder of Trialhub and FindMeCure about trial strategy for clinical trials. We speak about the amount of information necessary to digest in order to answer the many complex questions during trial start-up, and how starting from the templates of previous trials can both be time-saving, but may also limit your perspective on what is possible with this specific trial.

By asking the question of “what can go wrong” can help open the innovative power of clinical trial design. This can also help the understanding of patients and sites in the real world, and lead to better decisions. This question can also lead to better empathy with the stakeholders, and help anticipate some of the issues that may arise in the trial based on the design.

Finding data that can reliably support the answer for this question is another challenge yet to be solved. This is complicated further by the collaboration between the CROs and sponsors, where the responsibility to collect the data necessary to support key decisions may fall between two chairs.

Aligning your clinical trial to the real world would ideally lead to adjustments of the clinical trial as it is ongoing - but that is prohibitively expensive and difficult. When you are having trouble recruiting patients for your trial though, it may be worth the cost to pivot your trial during conduct. Here patient listening may be a way to understand what else might be possible for your trial.

Patient recruitment slowing down may be a lagging indicator of trouble with your trial design. Having conversations with your investigators proactively can help you uncover potential issues with your trial before they manifest as recruitment problems. Understanding the entire ecosystem that the clinical trial takes place in can help you understand which alternatives to participating in a trial the patients may value more.

Guest:

Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/

Trialhub and FindMeCure: https://trialhub.findmecure.com/

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

  continue reading

67 에피소드

Kaikki jaksot

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드